glp-1 agonist treatment information sources Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research GLP-1 Genetics: How Genes Affect

Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation.

GLP-1 drugs such as semaglutide are reshaping treatment of obesity, diabetes and cardiovascular disease with broader physiological effects now emerging.

Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, but the pace of weight loss is more moderate.

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore